Brian Abrahams
Stock Analyst at RBC Capital
(2.19)
# 2,847
Out of 4,996 analysts
433
Total ratings
42.55%
Success rate
-4.73%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics | Initiates: Outperform | $60 | $38.21 | +57.03% | 1 | Sep 25, 2025 | |
| INCY Incyte | Maintains: Sector Perform | $72 → $81 | $82.70 | -2.06% | 23 | Sep 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Sector Perform | $16 → $1.5 | $0.84 | +78.47% | 1 | Sep 16, 2025 | |
| KYMR Kymera Therapeutics | Initiates: Outperform | $70 | $56.25 | +24.44% | 1 | Sep 16, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Outperform | $144 → $149 | $142.00 | +4.93% | 22 | Sep 5, 2025 | |
| SION Sionna Therapeutics | Initiates: Sector Perform | $22 | $28.96 | -24.03% | 1 | Sep 3, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Outperform | $55 | $37.98 | +44.81% | 16 | Sep 2, 2025 | |
| AARD Aardvark Therapeutics | Maintains: Outperform | $20 → $19 | $13.23 | +43.61% | 4 | Aug 14, 2025 | |
| PTCT PTC Therapeutics | Maintains: Outperform | $60 → $63 | $58.99 | +6.80% | 21 | Aug 8, 2025 | |
| GILD Gilead Sciences | Maintains: Sector Perform | $96 → $98 | $112.10 | -12.58% | 32 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $11 | $14.70 | -25.17% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $40 | $21.05 | +90.02% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $430 → $405 | $385.74 | +4.99% | 55 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $9.41 | +6.27% | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $688 → $695 | $563.90 | +23.25% | 33 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $208 → $219 | $137.37 | +59.42% | 39 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $23 | $18.36 | +25.27% | 35 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 | $7.63 | +70.38% | 19 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $75 | $90.50 | -17.12% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $67 | $61.99 | +8.08% | 2 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $31 | $11.92 | +160.07% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $1.5 | $1.24 | +20.97% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $33 | $6.55 | +403.82% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $58 | $12.11 | +378.94% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $33.37 | +151.72% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $14.44 | +114.68% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.52 | +97.37% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $1.74 | +129.89% | 6 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $116.76 | +22.47% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $28.50 | +40.35% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $32 → $30 | $33.78 | -11.19% | 11 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $10.67 | +106.19% | 9 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $7.90 | +89.87% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $5.27 | +70.78% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $68.89 | -52.10% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $29.08 | - | 4 | Dec 4, 2017 |
Apogee Therapeutics
Sep 25, 2025
Initiates: Outperform
Price Target: $60
Current: $38.21
Upside: +57.03%
Incyte
Sep 24, 2025
Maintains: Sector Perform
Price Target: $72 → $81
Current: $82.70
Upside: -2.06%
aTyr Pharma
Sep 16, 2025
Downgrades: Sector Perform
Price Target: $16 → $1.5
Current: $0.84
Upside: +78.47%
Kymera Therapeutics
Sep 16, 2025
Initiates: Outperform
Price Target: $70
Current: $56.25
Upside: +24.44%
Neurocrine Biosciences
Sep 5, 2025
Maintains: Outperform
Price Target: $144 → $149
Current: $142.00
Upside: +4.93%
Sionna Therapeutics
Sep 3, 2025
Initiates: Sector Perform
Price Target: $22
Current: $28.96
Upside: -24.03%
Xenon Pharmaceuticals
Sep 2, 2025
Reiterates: Outperform
Price Target: $55
Current: $37.98
Upside: +44.81%
Aardvark Therapeutics
Aug 14, 2025
Maintains: Outperform
Price Target: $20 → $19
Current: $13.23
Upside: +43.61%
PTC Therapeutics
Aug 8, 2025
Maintains: Outperform
Price Target: $60 → $63
Current: $58.99
Upside: +6.80%
Gilead Sciences
Aug 8, 2025
Maintains: Sector Perform
Price Target: $96 → $98
Current: $112.10
Upside: -12.58%
Aug 8, 2025
Maintains: Sector Perform
Price Target: $12 → $11
Current: $14.70
Upside: -25.17%
Aug 7, 2025
Maintains: Outperform
Price Target: $39 → $40
Current: $21.05
Upside: +90.02%
Aug 5, 2025
Maintains: Sector Perform
Price Target: $430 → $405
Current: $385.74
Upside: +4.99%
Aug 5, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $9.41
Upside: +6.27%
Aug 4, 2025
Maintains: Sector Perform
Price Target: $688 → $695
Current: $563.90
Upside: +23.25%
Aug 1, 2025
Maintains: Outperform
Price Target: $208 → $219
Current: $137.37
Upside: +59.42%
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $18.36
Upside: +25.27%
Jun 30, 2025
Reiterates: Outperform
Price Target: $13
Current: $7.63
Upside: +70.38%
Jun 24, 2025
Maintains: Outperform
Price Target: $35 → $75
Current: $90.50
Upside: -17.12%
Jun 3, 2025
Reiterates: Outperform
Price Target: $67
Current: $61.99
Upside: +8.08%
May 15, 2025
Reiterates: Outperform
Price Target: $31
Current: $11.92
Upside: +160.07%
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $1.24
Upside: +20.97%
May 13, 2025
Maintains: Outperform
Price Target: $34 → $33
Current: $6.55
Upside: +403.82%
May 7, 2025
Maintains: Outperform
Price Target: $65 → $58
Current: $12.11
Upside: +378.94%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $33.37
Upside: +151.72%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $14.44
Upside: +114.68%
Mar 4, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.52
Upside: +97.37%
Mar 4, 2025
Reiterates: Sector Perform
Price Target: $4
Current: $1.74
Upside: +129.89%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $116.76
Upside: +22.47%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $28.50
Upside: +40.35%
Nov 1, 2024
Maintains: Sector Perform
Price Target: $32 → $30
Current: $33.78
Upside: -11.19%
Jun 5, 2024
Reiterates: Outperform
Price Target: $22
Current: $10.67
Upside: +106.19%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $7.90
Upside: +89.87%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $5.27
Upside: +70.78%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $68.89
Upside: -52.10%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $29.08
Upside: -